Pharmafile Logo
Pharmafocus logo
Advanced Search

Market access: Communicating the story effectively

February 15, 2012
Medical Communications

By Andy Buckland – Principal Medical Writer at Abacus International  Successful market access relies on a multitude of activities throughout …

Feature
Thought Leadership
Biogen image

Biogen to pay $563 million for Stromedix

February 15, 2012
Research and Development, Sales and Marketing Bioden Idec, R&D, STX-100, Stromedix

Biogen Idec will acquire the specialist immunology firm Stromedix for around $500 million. Biogen currently focuses on the development of …

News

Ablynx appoints Dr Andreas Menrad as its new chief scientific officer

February 15, 2012
Business Services, Research and Development, Sales and Marketing Abllynx, Menrad, nanobody

Dr Andreas Menrad has joined the Belgium-based firm Ablynx as its new chief scientific officer. Dr Menrad has over 20 …

Appointment

New PV Legislation Implementation Plan by the European Medicines Agency

February 14, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing wainwright associates; Pharmacovigilance legislation

The European Medicines Agency has released an implementation plan for the pharmacovigilance legislation, which sets out milestone dates for different …

News
Press release

Virgo bolsters specialist value and access service

February 14, 2012
Medical Communications Jo Jones, NHS, Virgo, Virgo Health Communications

Virgo Health Communications has expanded its UK value and access expertise with the appointment of Tristan Mulholland.Tristan joins as Account …

News

Merck’s eye drug Zioptan gains FDA approval

February 14, 2012
Sales and Marketing Merck, Pfizer, Xalatan, Zioptan

The FDA has approved Merck’s eye solution Zioptan to treat a common eye condition. Zioptan (tafluprost ophthalmic solution) can now …

News

Premier Research appoints Sean Russell vice president, Marketing

February 14, 2012
Research and Development, Sales and Marketing Premier Research, Quintiles, Sean Russell

Premier Research Group has announced the appointment of Sean Russell to the position of vice president, marketing.In this position, Russell …

Appointment
Herceptin and Tyverb image

NICE cannot recommend breast cancer drugs

February 14, 2012
Sales and Marketing GSK, Herceptin, NHS, NICE, Roche, Tyverb

NICE is not recommending GlaxoSmithKline’s Tyverb or Roche’s Herceptin for use in certain breast cancer patients. The watchdog said in …

News
Shire picture

Robust sales for Shire

February 13, 2012
Sales and Marketing Replagal, Shire, Vpriv, Vyvanse

A rise in the use of attention deficit and hyperactivity disorder drugs has helped push Shire’s turnover past $4 billion …

News
Lonza picture

Lonza forges joint venture with South Africa for HIV drugs

February 13, 2012
Manufacturing and Production HIV, Lonza, South Africa

Swiss contract manufacturer Lonza has signed a joint venture agreement with the government of South Africa that could significantly reduce …

News
Abbott image

Abbott plans €85m investment in Irish facility

February 13, 2012
Manufacturing and Production Abbott. IDA, Ireland, Xinlay

Abbott Laboratories has said it will invest around €85 million in its manufacturing facility in Sligo, Ireland, more than doubling …

News

Excipient certification scheme launches

February 13, 2012
Manufacturing and Production EXCiPACT, GDP, GMP, manufacturing

A consortium of industry associations has launched a certification scheme for pharmaceutical excipients to make it easier for drugmakers to …

News

Pharma manufacturing news in brief

February 13, 2012
Manufacturing and Production Bosch, Lilly/Bend Research, Neuland, OctoPlus Ferring and CHEMO Particle Sciences

Neuland posts revenue gains, Bosch buys Eisi machinery, plus deals for Lilly/Bend Research, OctoPlus/Ferring and CHEMO/Particle Sciences.

News
carlyle_ware

Carlyle Ware joins the Fishawack Group

February 13, 2012
Business Services, Medical Communications, Sales and Marketing Fishawack Group, PR, fishawack

Med comms specialist the Fishawack Group has appointed Carlyle Ware as its group commercial director. Ware has over 13 years’ …

Appointment

NHS productivity not declining: Lancet study

February 13, 2012
Sales and Marketing Lancet, Lansley, NHS reform

A new study by the Lancet has shown that productivity in the NHS has improved over the past ten years.  …

News

SHL takes part in PharmTech.com’s “Pointed Debate: Expert Views on Injectables”

February 13, 2012
Manufacturing and Production auto injector, auto-injector, pen injector, shl group

SHL recently had the opportunity to participate along with various other experts in the industry in a questionnaire held by …

Feature
Thought Leadership

Quintiles launches new Asian market service

February 13, 2012
Research and Development Asia, Quintiles, emerging markets

Contract research and consulting firm Quintiles has launched two new services to help pharma improve their chances of developing and …

News
Roche picture

FDA grants Roche’s pertuzumab priority review

February 10, 2012
Sales and Marketing Herceptin, Roche, pertuzumab

The FDA has accepted Roche’s potential breast cancer treatment pertuzumab for appraisal and granted the drug priority review. The proposed …

News
Michael Quiqueran-Beaujeu (left) and João Rocha

Lundbeck appoints European leaders

February 10, 2012
Medical Communications, Sales and Marketing Cipralex, Lundbeck

Lundbeck has appointed two new regional vice presidents for European markets, in time for new drug launches.João Rocha is to …

News

PR agencies warn of ‘race to the bottom’

February 10, 2012
Medical Communications HCA, PR

A new survey of PR agencies working in healthcare has highlighted concerns about cost-cutting which they say could lower standards …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026